ダウンロード数: 284
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 15_0522.pdf | 529.79 kB | Adobe PDF | 見る/開く |
| タイトル: | 尿路感染症に対するCephalexinの応用 |
| その他のタイトル: | Cephalexin for urinary tract infection |
| 著者: | 石神, 襄次  原, 信二 三田, 俊彦 |
| 著者名の別形: | Ishigami, Joji Hara, Shinji Mita, Toshihiko |
| キーワード: | Adolescent Adult Aged Bacteria/drug effects Cephalosporins/adverse effects/blood/pharmacology/therapeutic use/urine Child Child, Preschool Female Humans Male Middle Aged Urinary Tract Infections/drug therapy |
| 発行日: | Jul-1969 |
| 出版者: | 京都大学医学部泌尿器科学教室 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 15 |
| 号: | 7 |
| 開始ページ: | 522 |
| 終了ページ: | 530 |
| 抄録: | 1) Clinical results. CEPHALEXIN (CEX) was orally administered to fifty cases of urinary tract infection. Clinical result was as follows: excellent 35, fair 7 and non-effective 8. The effectiveness was, therefore, estimated to be 84%. 2) Blood levels. The highest blood level after single administration of 0.5 or 1.0 gram of CEX was observed at one hour. Then, the blood level fell rapidly, although the effective level continued to four hours. 3) Urinary excretion. Eighty percent of CEX of 1.0 g in a single dosage was proved to be excreted in urine in six hours. 4) Antimicrobial potency. Approximately 1/2 to 1/4 of antimicrobial potency of CER was observed against Staphylococcus, E. coli, Proteus and Klebsiella. 5) Side effects. No side effect worthy to mention was observed. |
| URI: | http://hdl.handle.net/2433/120019 |
| PubMed ID: | 5388484 |
| 出現コレクション: | Vol.15 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。